For some Big Pharma companies, sales in China contributed to more than 10 percent of global sales, making China a top market ...

This week, medical tech firm Medtronic opted for tapping into China's biotech advancements. On Monday, it launched a digital healthcare innovation base at BioPark in the Beijing Economic-Technological ...

ImmuneOnco Biopharmaceuticals has shown Chinese biotechs are far from immune to the pressures to prioritize pipelines. | ...

The China-based biotech was formed in 2018 by Ascendis Pharma and an investor syndicate led by Vivo Capital. The biotech is designed to develop and commercialize Ascendis’ endocrinology ...

“Absolutely, China stocks are investible now, as in anything,” said Jenny Johnson, president and CEO of Templeton, the California-based firm with US$1.58 trillion of assets. China’s success ...

This week, medical tech firm Medtronic opted for tapping into China's biotech advancements. On Monday, it launched a digital healthcare innovation base at BioPark in the Beijing Economic ...